Kubota H, Okazaki H, Onuma M, Kano S, Hattori M, Minato N
Department of Veterinary Medicine, Hokkaido University, Japan.
J Immunol. 1990 Dec 1;145(11):3924-31.
Lymphocytes are shown to express a limited number of a unique category of membrane Ag, such as Thy-1, Ly-6, Ly-31, and Qa-2, that are covalently linked to the membrane phosphatidylinositol (PI). We have identified a new glycosyl-phosphatidylinositol (GPI)-anchored lymphocyte Ag, B7, by using a mAb and have determined the primary structure by cDNA cloning. B7 Ag was expressed on the majority, if not all, of the mature lymphocytes of both T and B lineages, including strongly CD3+ thymocytes, most splenic T cells, and approximately 60% of splenic IgM+ B cells, whereas the expression of B7 Ag on bone marrow cells was negligible. The expression of B7 Ag was nearly completely abolished with as little as 2 mU of PI-specific phospholipase C per ml, which did not completely eliminate Ly-6C and Thy-1 expression. Unlike the expression of other GPI-linked lymphocyte Ag, the expression of B7 was rapidly down-regulated upon the activation of T cells by mitogens or IL-2 both in vitro and in vivo. Immunoprecipitation analysis revealed that B7 Ag was an approximately 12-kDa protein. With a CDM8 expression vector, a cDNA encoding B7 Ag was cloned, and it was confirmed that the B7 Ag on cDNA-transfected cells was indeed PI-specific phospholipase C sensitive. The B7 cDNA contained an open reading frame of 222 bp including a typical N-terminal leader sequence and a characteristic sequence at the C terminus encoding hydrophobic amino acids. A computer search revealed no significant homology to any known molecule at both DNA and amino acid sequence levels. Northern blot analysis indicated that the B7 transcript was expressed on lymphohematopoietic tissues, including thymus, spleen, and bone marrow, but not on other organs, such as liver, kidney, and brain. The results indicated that B7 Ag is a new member of the GPI-anchored proteins which is selectively expressed on mature resting but not activated lymphocytes.
淋巴细胞可表达数量有限的一类独特的膜抗原,如Thy-1、Ly-6、Ly-31和Qa-2,它们与膜磷脂酰肌醇(PI)共价连接。我们利用单克隆抗体鉴定出一种新的糖基磷脂酰肌醇(GPI)锚定的淋巴细胞抗原B7,并通过cDNA克隆确定了其一级结构。B7抗原在T和B谱系的大多数(如果不是全部)成熟淋巴细胞上表达,包括强CD3+胸腺细胞、大多数脾T细胞以及约60%的脾IgM+B细胞,而B7抗原在骨髓细胞上的表达可忽略不计。每毫升低至2 mU的PI特异性磷脂酶C就能几乎完全消除B7抗原的表达,但这并未完全消除Ly-6C和Thy-1的表达。与其他GPI连接的淋巴细胞抗原的表达不同,无论是在体外还是体内,T细胞经丝裂原或IL-2激活后,B7的表达都会迅速下调。免疫沉淀分析显示B7抗原是一种约12 kDa的蛋白质。利用CDM8表达载体克隆了编码B7抗原的cDNA,并证实cDNA转染细胞上的B7抗原确实对PI特异性磷脂酶C敏感。B7 cDNA包含一个222 bp的开放阅读框,包括一个典型的N端前导序列和C端编码疏水氨基酸的特征序列。计算机搜索显示,在DNA和氨基酸序列水平上,它与任何已知分子均无明显同源性。Northern印迹分析表明,B7转录本在包括胸腺、脾脏和骨髓在内的淋巴造血组织中表达,但在肝脏、肾脏和大脑等其他器官中不表达。结果表明,B7抗原是GPI锚定蛋白的一个新成员,在成熟静止而非活化的淋巴细胞上选择性表达。